Insights

Unique bioplastic lens Novol Bio offers a 95% bioplastic optical Rx lens with high Abbe value, ultra-clear optics, and very light weight, presenting a distinctive material advantage that can be leveraged to position premium value in optical retailers and clinics seeking high-quality, sustainable lens solutions.

Direct-from-polymer manufacturing The lens can be formed to finished prescription directly from the polymer, bypassing the traditional surfacing step and reducing waste, which can translate to shorter production cycles and lower material waste costs for partners.

Early-stage funding With current revenue under $1M and an investment of $2.7M, there is an opportunity to engage early adopters and strategic partners in co-development, pilot programs, and joint go-to-market efforts to accelerate scale.

Targeted market fit Focus on myopia patients with high diopter prescriptions and clinicians seeking high-clarity, lightweight lenses can unlock niche adoption in optical retailers, ophthalmology clinics, and vision care networks.

Growth potential partnerships Align with large life sciences and diagnostics players or equipment and materials suppliers adjacent to consumer optics to explore co-marketing, distribution, or integration opportunities leveraging their sales channels and customer bases.

Similar companies to Novol Bio

Novol Bio Tech Stack

Novol Bio uses 5 technology products and services including WordPress, Google Fonts API, Twemoji, and more. Explore Novol Bio's tech stack below.

  • Content Management System
  • Google Fonts API
    Font Scripts
  • Twemoji
    Font Scripts
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages

Novol Bio's Email Address Formats

Novol Bio uses at least 1 email format:
Novol Bio Email FormatsExamplePercentage
First@novolbio.comJohn@novolbio.com
100%

Frequently Asked Questions

What is Novol Bio's official website and social media links?

Minus sign iconPlus sign icon
Novol Bio's official website is novolbio.com and has social profiles on LinkedIn.

How much revenue does Novol Bio generate?

Minus sign iconPlus sign icon
As of July 2026, Novol Bio's annual revenue is estimated to be <$1M.

What is Novol Bio's NAICS code?

Minus sign iconPlus sign icon
Novol Bio's NAICS code is 31-33 - Manufacturing.

How many employees does Novol Bio have currently?

Minus sign iconPlus sign icon
As of July 2026, Novol Bio has approximately 4 employees across 1 continents, including North America. Key team members include Advisory Board Member: A. H. Explore Novol Bio's employee directory with LeadIQ.

What industry does Novol Bio belong to?

Minus sign iconPlus sign icon
Novol Bio operates in the Consumer Goods industry.

What technology does Novol Bio use?

Minus sign iconPlus sign icon
Novol Bio's tech stack includes WordPress, Google Fonts API, Twemoji, jQuery and PHP.

What is Novol Bio's email format?

Minus sign iconPlus sign icon
Novol Bio's email format typically follows the pattern of First@novolbio.com. Find more Novol Bio email formats with LeadIQ.

How much funding has Novol Bio raised to date?

Minus sign iconPlus sign icon
As of July 2026, Novol Bio has raised $2.7M in funding. The last funding round occurred on Sep 04, 2019.

When was Novol Bio founded?

Minus sign iconPlus sign icon
Novol Bio was founded in 2014.
Novol Bio logo

Novol Bio

Consumer GoodsCalifornia, United States2-10 Employees

Novol Bio is a small manufacturing company based in San Leandro, California. It is developing an optical prescription lens constructed from a bioplastic material with roughly 95% bioplastic content. The lens is mid-index and designed to deliver high clarity for individuals with myopia and high diopter prescriptions.

Its material can be formed directly into a finished prescription from the polymer, bypassing a separate surfacing step and significantly reducing waste. The company operates with a small team and focuses on supplying this bioplastic optical solution to the ophthalmic lens market.

Section iconCompany Overview

NAICS Code
31-33 - Manufacturing
Founded
2014
Employees
2-10

Section iconFunding & Financials

  • $2.7M

    Novol Bio has raised a total of $2.7M of funding over 6 rounds. Their latest funding round was raised on Sep 04, 2019 as a Non Equity Assistance.

  • <$1M

    Novol Bio's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.